Medtronic reveals cardiac mapping and ablation software clearances
Published . Updated .
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.
Directly affected
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.
Source: MedTech Dive
How far Medtronic (MDT) has moved since 1 Oct 2026
Since the first closing price after “Medtronic reveals cardiac mapping and ablation software clearances,” Medtronic (MDT) is +7.46%. The S&P 500 fund (SPY) is -0.40% over the same days, a +7.85% difference versus the market.
Official trades in Medtronic (MDT) around 1 Oct 2026
- Kevin Hern sell Boston Scientific (BSX) ($50,001 - $100,000). That is 22 days before publication, inside 30 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
- Kevin Hern sell Boston Scientific (BSX) ($50,001 - $100,000). That is 27 days before publication, inside 30 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
- Kevin Hern sell Boston Scientific (BSX) ($1,001 - $15,000). That is 28 days before publication, inside 30 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
- Kevin Hern sell Boston Scientific (BSX) ($15,001 - $50,000). That is 31 days before publication, inside 60 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
- Donald J Trump buy Boston Scientific (BSX) ($15,001 - $50,000). That is 34 days before publication, inside 60 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
- Kevin Hern sell Medtronic (MDT) ($15,001 - $50,000). That is 38 days before publication, inside 60 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
- Gilbert Cisneros buy Boston Scientific (BSX) ($1,001 - $15,000). That is 44 days before publication, inside 60 days. The filing is listed beside the story “Medtronic reveals cardiac mapping and ablation software clearances.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Medtronic (MDT)
Companies mentioned with this story
- MDT Medtronic
Medtronic (MDT) is linked, with no stored direction, high confidence in the 1 Oct 2026 story “Medtronic reveals cardiac mapping and ablation software clearances.” Reason on file: The reported development directly names MEDTRONIC PLC in the headline; GA resolved that company to MDT
- BSX Boston Scientific
Boston Scientific (BSX) is linked, with no stored direction, high confidence in the 1 Oct 2026 story “Medtronic reveals cardiac mapping and ablation software clearances.” Reason on file: The reported development directly names BOSTON SCIENTIFIC CORP in the summary; GA resolved that company to BSX
Medtronic (MDT)
“Medtronic reveals cardiac mapping and ablation software clearances” (1 Oct 2026) reaches Medtronic (MDT) through this story.
What ties Medtronic (MDT) to the headline is this: The reported development directly names MEDTRONIC PLC in the headline; GA resolved that company to MDT
A second company, Boston Scientific (BSX), is listed for a different reason: The reported development directly names BOSTON SCIENTIFIC CORP in the summary; GA resolved that company to BSX
Dates and price levels for Medtronic (MDT)
BSX traded between 41.39 and 45.74 across 20 sessions. The latest close on file is 45.05. MDT traded between 85.22 and 96.47 across 20 sessions. The latest close on file is 92.79.
What the saved facts support for Medtronic (MDT)
21 out of 100
“Medtronic reveals cardiac mapping and ablation software clearances” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.